This approach leads to improved glycemic control and substantial weight loss, with clinical trials demonstrating HbA1c reductions of 1.9% to 2.4% and mean weight loss of approximately 15-21% in the SURMOUNT-1 trial, with up to 22.5% weight loss observed in some patients at the highest doses
The STEP trials evaluating semaglutide 2.4 mg for weight management reported gallbladder disorders in approximately 1.6-2.6% of participants receiving the medication versus 0.7-1.2% receiving placebo
yet, excessive or persistent inflammatory reactions may cause tissue damage and even exacerbate disease progression (63)
Joint problems, sleep apnea, and fatty liver disease frequently accompany significant weight gain
Lunch: Turkey sandwich: 23 ounces of turkey topped with 1 sliced avocado, red onion, cup of spinach, and tomato on whole-grain bread This lunch hits everything on the semaglutide diet plan wishlist
Article Information: Last Updated: January 24, 2026 Reviewed By: Dr